Home › Diffuse Intrinsic Pontine Glioma › Michigan › Ann Arbor
Diffuse Intrinsic Pontine Glioma clinical trials in Ann Arbor, MI
6 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RecruitingPhase 2
- C.S. Mott Children's Hospital, Ann Arbor
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RecruitingPhase 1/2
- C S Mott Children's Hospital, Ann Arbor
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- C.S. Mott Children's Hospital, Ann Arbor
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- C.S. Mott Children's Hospital, Ann Arbor
Combination Therapy for the Treatment of Diffuse Midline Gliomas
RecruitingPhase 2
- University of Michigan, Ann Arbor
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- C.S. Mott Children's Hospital, Ann Arbor
Diffuse Intrinsic Pontine Glioma trials in other cities
- Washington, DC11 studies
- Philadelphia, PA10 studies
- Seattle, WA10 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Houston, TX10 studies
- Chicago, IL9 studies
- Boston, MA9 studies
- Durham, NC9 studies
- Aurora, CO8 studies
- Miami, FL6 studies
- St. Louis, MO5 studies
Other studies in Ann Arbor
- Breast Cancer27 studies
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Stroke12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.